Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of open-label pramipexole extended release in Parkinson's disease
2007-004235-37Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pramipexole in Parkinson's disease (PD), sponsored by Boehringer Ingelheim. Primary endpoint: Long-term safety and tolerability of pramipexole extended release. Started Nov 2007; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2007-004235-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004235-37.